Clinical trial · Observational
Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients
The Ohio State University Guardant Shield™ Colorectal Cancer Screening Project
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial evaluates the use of a blood test (Guardant Shield™) for colorectal cancer screening. Colorectal cancer is the third leading cancer and cause of death in the United States. Screening may help doctors find colorectal cancer early when it is easier to treat yet nearly a third of all people eligible for screening have never had a screening test performed. Currently, doctors use a stool- based test such as the fecal immunochemical test (FIT) and visual tests such as a colonoscopy. Blood based testing such as Guardant Shield™, may provide a quick and effective way to screen patients that are hard to reach or with limited access (underserved).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Carcinoma | Colorectal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biospecimen Collection | Procedure | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Screening (biospecimen collection)
- description
- Participants undergo blood specimen collection and complete survey on study. Participants may optionally undergo standard of care FIT testing on study.
- interventionNames
- Procedure: Biospecimen Collection
- Other: Survey Administration
Primary outcomes (5)
- measure
- Number of patients consented
- timeFrame
- Up to 2 years
- description
- The number and percentage of patients consented out of those approached to be summarized.
- measure
- Percentage of patients consented
- timeFrame
- Up to 2 years
- description
- The number and percentage of patients consented out of those approached to be summarized.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged 45 years of age and older who are in need of colorectal screening * Do not have a history of cancer * Able to read and understand English * Have a provider to receive the results of the test and who will follow-up test results * Able to provide informed consent
References
Publications (0)
Data not yet available